We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Hawkins (HWKN) Up 51% in 6 Months: What's Driving the Stock?
Read MoreHide Full Article
Hawkins, Inc.’s (HWKN - Free Report) shares have rallied 50.9% in the past six months. Owing to the upside, the stock outperformed the industry’s rise of 8.5% over the same time frame. The company has topped the S&P 500’s 8.1% rise.
Image Source: Zacks Investment Research
Let’s look at the factors driving this Zacks Rank #2 (Buy) stock.
What’s Favoring Hawkins?
In the second quarter of fiscal 2024, the company achieved robust results, witnessing a significant 27.9% increase in earnings from the preceding quarter’s levels. The Water Treatment segment showcased a strong performance during the quarter, marked by an impressive 17% year-over-year surge in revenues and 70% growth in operating income. This success is attributed to the profit expansion in the company's established business and recent strategic acquisitions, such as the EcoTech Enterprises in July. The addition of EcoTech Enterprises strengthened its position in the water treatment market.
Leveraging its solid financial standing, Hawkins is committed to enhancing its Water Treatment portfolio by acquiring six additional locations through two acquisitions after the close of the quarter. With a positive outlook for sustained growth, the company anticipates ongoing expansion in the Water Treatment segment throughout the year.
During the quarter, the company utilized record quarterly operating cash flow to repay $28.6 million in debt, resulting in a total outstanding debt of $60 million. This marks a noteworthy reduction in the debt-to-trailing 12-month adjusted EBITDA ratio, which stands at 0.45x, down significantly from the 0.96x recorded at the end of the fiscal 2023.
Surpassing expectations, the company reported earnings of $1.10 per share in the second quarter of fiscal 2024, exceeding the Zacks Consensus Estimate of $1.00. This marks the fourth consecutive quarter in which the company outperformed earnings projections, with an average surprise of 27.5%.
With a positive trajectory, the consensus estimate for earnings in the current fiscal year has been revised upward by 1.7% in the past 60 days. The Zacks Consensus Estimate for fiscal 2024 earnings is pegged at $3.46 per share, indicating 20.9% growth from the previous year’s figure.
The consensus estimate for the third quarter of fiscal 2024 earnings is pegged at 61 cents. These favorable estimate revisions instill confidence among investors in the company's performance and prospects.
The consensus estimate for AXTA’s current-year earnings is pegged at $1.58, indicating year-over-year growth of 6.8%. AXTA beat the Zacks Consensus Estimate in three of the last four quarters and missed one, with the average earnings surprise being 6.7%. The company’s shares have increased 34.3% in the past year.
The Zacks Consensus Estimate for CBT’s current-year earnings has been revised upward by 4.4% in the past 60 days. CBT beat the Zacks Consensus Estimate in three of the last four quarters. It delivered a trailing four-quarter earnings surprise of 2.3%, on average. The stock has rallied around 27.7% in a year.
The consensus estimate for Linde’s current fiscal year earnings is pegged at $14.11, indicating a year-over-year surge of 14.8%. AGI beat the Zacks Consensus Estimate in all of the last four quarters, with the average earnings surprise being 5.7%. The company’s shares have surged 26.1% in the past year.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Hawkins (HWKN) Up 51% in 6 Months: What's Driving the Stock?
Hawkins, Inc.’s (HWKN - Free Report) shares have rallied 50.9% in the past six months. Owing to the upside, the stock outperformed the industry’s rise of 8.5% over the same time frame. The company has topped the S&P 500’s 8.1% rise.
Image Source: Zacks Investment Research
Let’s look at the factors driving this Zacks Rank #2 (Buy) stock.
What’s Favoring Hawkins?
In the second quarter of fiscal 2024, the company achieved robust results, witnessing a significant 27.9% increase in earnings from the preceding quarter’s levels. The Water Treatment segment showcased a strong performance during the quarter, marked by an impressive 17% year-over-year surge in revenues and 70% growth in operating income. This success is attributed to the profit expansion in the company's established business and recent strategic acquisitions, such as the EcoTech Enterprises in July. The addition of EcoTech Enterprises strengthened its position in the water treatment market.
Leveraging its solid financial standing, Hawkins is committed to enhancing its Water Treatment portfolio by acquiring six additional locations through two acquisitions after the close of the quarter. With a positive outlook for sustained growth, the company anticipates ongoing expansion in the Water Treatment segment throughout the year.
During the quarter, the company utilized record quarterly operating cash flow to repay $28.6 million in debt, resulting in a total outstanding debt of $60 million. This marks a noteworthy reduction in the debt-to-trailing 12-month adjusted EBITDA ratio, which stands at 0.45x, down significantly from the 0.96x recorded at the end of the fiscal 2023.
Surpassing expectations, the company reported earnings of $1.10 per share in the second quarter of fiscal 2024, exceeding the Zacks Consensus Estimate of $1.00. This marks the fourth consecutive quarter in which the company outperformed earnings projections, with an average surprise of 27.5%.
With a positive trajectory, the consensus estimate for earnings in the current fiscal year has been revised upward by 1.7% in the past 60 days. The Zacks Consensus Estimate for fiscal 2024 earnings is pegged at $3.46 per share, indicating 20.9% growth from the previous year’s figure.
The consensus estimate for the third quarter of fiscal 2024 earnings is pegged at 61 cents. These favorable estimate revisions instill confidence among investors in the company's performance and prospects.
Hawkins, Inc. Price and Consensus
Hawkins, Inc. price-consensus-chart | Hawkins, Inc. Quote
Zacks Rank & Other Key Picks
Some other top-ranked stocks in the Basic Materials space are Axalta Coating Systems Ltd. (AXTA - Free Report) , sporting a Zacks Rank #1 (Strong Buy), and Cabot Corporation (CBT - Free Report) and Linde plc (LIN - Free Report) , each carrying a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for AXTA’s current-year earnings is pegged at $1.58, indicating year-over-year growth of 6.8%. AXTA beat the Zacks Consensus Estimate in three of the last four quarters and missed one, with the average earnings surprise being 6.7%. The company’s shares have increased 34.3% in the past year.
The Zacks Consensus Estimate for CBT’s current-year earnings has been revised upward by 4.4% in the past 60 days. CBT beat the Zacks Consensus Estimate in three of the last four quarters. It delivered a trailing four-quarter earnings surprise of 2.3%, on average. The stock has rallied around 27.7% in a year.
The consensus estimate for Linde’s current fiscal year earnings is pegged at $14.11, indicating a year-over-year surge of 14.8%. AGI beat the Zacks Consensus Estimate in all of the last four quarters, with the average earnings surprise being 5.7%. The company’s shares have surged 26.1% in the past year.